Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07661212Not yet recruiting
Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Bakırköy Dr. Sadi Konuk Research and Training Hospital. Primary endpoint: Postoperative Quality of Recovery at 24 hours. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07661212.